Clinical trial registry record

Multidimensional Frailty Assessment and Post-Transplant Outcomes in Liver Transplant Candidates

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated February 17, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07414095
Last registry update
February 17, 2026
Status
Recruiting
Phase
Phase not reported
Sponsor
Izmir Bakircay University
Enrollment
60
Countries
Turkey (Türkiye)
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
60
Population
ALL · 18 Years to 65 Years
Duration
2025-12-15 to 2026-08-01
Intervention
Comprehensive Observational Assessment in Liver Transplant Candidates
Comparator
Not reported
Outcomes measured
Liver Frailty Index (LFI) — At hospital admission when liver transplantation is confirmed.; 6-Minute Walk Test (6MWT) Distance — At hospital admission when liver transplantation is confirmed.; Karnofsky Performance Status (KPS) — At hospital admission when liver transplantation is confirmed.; Activities of Daily Living (ADL) — At hospital admission when liver transplantation is confirmed.; Nutritional Risk Index (NRI) — At hospital admission when liver transplantation is confirmed.; Phase Angle Measured by Bioelectrical Impedance Analysis (BIA) — At hospital admission when liver transplantation is co…; Sarcopenia Diagnosis According to the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) Criteria — At ho…; Handgrip Strength (HGS) — At hospital admission when liver transplantation is confirmed.; Skeletal Muscle Index (SMI) — At hospital admission when liver transplantation is confirmed.; Gait Speed (4-meter walk test) — At hospital admission when liver transplantation is confirmed.; Hospital Anxiety and Depression Scale - Anxiety Subscale (HADS-A) — At hospital admission when liver transplantation is…; Hospital Anxiety and Depression Scale - Depression Subscale (HADS-D) — At hospital admission when liver transplantation…; Hospital Anxiety and Depression Scale - Total Score (HADS Total) — At hospital admission when liver transplantation is…; Charlson Comorbidity Index - Orthotopic Liver Transplant (CCI-OLT) — At hospital admission when liver transplantation i…; Intensive Care Unit (ICU) Length of Stay — From the day of liver transplantation until ICU discharge (within 30 days po…; Hospital Length of Stay — From the day of liver transplantation until hospital discharge (within 30 days post-transplan…; Postoperative Mechanical Ventilation Duration — From the day of liver transplantation until extubation or 30 days post-…; Early Postoperative Complications (within 30 days) — Within 30 days after liver transplantation.; 30-Day Mortality — Within 30 days after liver transplantation.
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Frailty · 100%Title contains controlled term: frailty. Abstract contains controlled term: frailty. Title supplies longevity context: frailty, frail. Study type is explicitly identified as OBSERVATIONAL.

Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.